State X-Waiver Statutes and Buprenorphine Prescriber Rates After Federal X-Waiver Elimination, 2021-2023.
- DOI
- 10.1016/j.amepre.2026.108508
- Published
- 2026 Jul 16
- Container
- American journal of preventive medicine
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.amepre.2026.108508,
title = {State X-Waiver Statutes and Buprenorphine Prescriber Rates After Federal X-Waiver Elimination, 2021-2023.},
author = {Wolde F and Martin BC and Acharya M and Gressler L and Li C and Painter JT and Hayes CJ},
year = {2026},
journal = {American journal of preventive medicine},
doi = {10.1016/j.amepre.2026.108508},
url = {https://doi.org/10.1016/j.amepre.2026.108508}
}RIS
TY - JOUR TI - State X-Waiver Statutes and Buprenorphine Prescriber Rates After Federal X-Waiver Elimination, 2021-2023. AU - Wolde F AU - Martin BC AU - Acharya M AU - Gressler L AU - Li C AU - Painter JT AU - Hayes CJ PY - 2026 JO - American journal of preventive medicine DO - 10.1016/j.amepre.2026.108508 UR - https://doi.org/10.1016/j.amepre.2026.108508 ER -
APA
F, W., BC, M., M, A., L, G., C, L., JT, P., & CJ, H. (2026). State X-Waiver Statutes and Buprenorphine Prescriber Rates After Federal X-Waiver Elimination, 2021-2023.. American journal of preventive medicine. https://doi.org/10.1016/j.amepre.2026.108508
Source records
- pubmed · retrieved 2026-09-26T13:15:15.165Z